Bortezomib 3.5mg powder for solution for injection (Velcade)

Publisher:
Glenmark Pharmaceuticals Europe Ltd
Publication date:
19 April 2013

Abstract

Section 4.4 has been updated to include a section on progressive multifocal leukoencephalopathy (PML).  Very rare cases of PML have been reported.  Monitoring at regular intervals for new or worsening neurological symptoms or signs that may be suggestive of PML is recommended.